Abstract
Five fluoroquinolones were tested against 300 staphylococci from a wide variety of US medical centers including 150 strains resistant to penicil-linase-resistant penicillins (PRP-resistant). Ten ciprofloxacin-resistant strains of PRP-resistantStaphylococcus aureus were relatively resistant to the other fluoroquinolones, but the remaining 290 isolates were susceptible to all five drugs at established or anticipated breakpoint concentrations. The relative potency of the study drugs could be ranked as follows: CI-960>PD 131628>sparfloxacin > ciprofloxacin > ofloxacin. All five drugs were bactericidal against PRP-resistant and PRP-susceptible staphylococci.
Similar content being viewed by others
References
Barry AL, Jones RN In vitro activity of ciprofloxacin against gram-positive cocci. American Journal of Medicine 1986, 82: 27–32.
Daum TE, Schaberg DR, Terpenning MS, Sottile WS, Kauffman CA Increasing resistance ofStaphylococcus aureus to ciprofloxacin. Antimicrobial Agents and Chemotherapy 1990, 34: 1862–1863.
Raviglione MC, Boyle JF, Mariuz P, Pablos-Mendez A, Cotes H, Merlo A Ciprofloxacin-resistant methicillin-resistantStaphylococcus aureus in an acute-care hospital. Antimicrobial Agents and Chemotherapy 1990, 34: 2050–2054.
Kojima T, Inoue M, Mitsuhashi S In vitro activity of AT-4140 against quinolone- and methicillin-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1990, 34: 1123–1127.
Chaudhry AZ, Knapp CC, Sierra-Madero J, Washington JA Antistaphylococcal activities of sparfloxacin (CI-978, AT-4140), ofloxacin, and ciprofloxacin. Antimicrobial Agents and Chemotherapy 1990, 34: 1843–1845.
Cohen MA, Huband MD, Mailloux GB, Yoder SL, Roland GE, Domagala JM, Heifetz CL In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine antiinfective. Antimicrobial Agents and Chemotherapy 1991, 35: 141–146.
Norby SR, Jonsson M Comparative in vitro activity of PD 127391, a new fluorinated 4-quinolone derivative. Antimicrobial Agents and Chemotherapy 1988, 32: 1278–1281.
Jones RN, Barry AL, Gardiner RV, Packer RR The prevalence of staphylococcal resistance to penicillinase-resistant penicillins, a retrospective and prospective national surveillance trial of isolates from 40 medical centers. Diagnostic Microbiology and Infectious Disease 1989, 12: 385–394.
National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved standard M7-A2. NCCLS, Villanova, PA, 1990.
Pearson RD, Steigbigel RT, Davis HT, Chapman SW Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrobial Agents and Chemotherapy 1980, 19: 699–708.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barry, A.L., Fuchs, P.C. Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 10, 168–171 (1991). https://doi.org/10.1007/BF01964451
Issue Date:
DOI: https://doi.org/10.1007/BF01964451